Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Italiano

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)T Valentin, A Le Cesne, I Ray-Coquard, et al.
ESMO Open|May 23, 2025
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancerD S Hong, R-H Xu, L Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Gynecologic Oncology|July 14, 2022
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 studyD M O'Malley, G M Bariani, P A Cassier, et al.
Surgical Oncology|June 15, 2019
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patientsC Honoré, J B Delhorme, E Nassif, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2025
Corrigendum to "Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)": [Ann Oncol 26 (2015) 2168-2173]E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma GroupA Italiano, N Penel, Y-M Robin, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2019
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC studyA Le Cesne, P Marec-Berard, J-Y Blay, et al.
British Journal of Cancer|August 8, 2013
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma GroupP A Cassier, A Lefranc, E Y Amela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2022
Impact of acetaminophen on the efficacy of immunotherapy in cancer patientsA Bessede, A Marabelle, J P Guégan, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)T Valentin, A Le Cesne, I Ray-Coquard, et al.
ESMO Open|May 23, 2025
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancerD S Hong, R-H Xu, L Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Gynecologic Oncology|July 14, 2022
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 studyD M O'Malley, G M Bariani, P A Cassier, et al.
Surgical Oncology|June 15, 2019
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patientsC Honoré, J B Delhorme, E Nassif, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2025
Corrigendum to "Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)": [Ann Oncol 26 (2015) 2168-2173]E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma GroupA Italiano, N Penel, Y-M Robin, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2019
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC studyA Le Cesne, P Marec-Berard, J-Y Blay, et al.
British Journal of Cancer|August 8, 2013
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma GroupP A Cassier, A Lefranc, E Y Amela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2022
Impact of acetaminophen on the efficacy of immunotherapy in cancer patientsA Bessede, A Marabelle, J P Guégan, et al.
Pageof 14